Navigation Links
DWHP Invests in Pacific Data Designs
Date:11/5/2007

SAN FRANCISCO, Nov. 5 /PRNewswire/ -- Pacific Data Designs, Inc. ("PDD"), a specialized Contract Research Organization ("CRO") that provides data management and statistical services to the biotech, medical device, and pharmaceutical industries, today announced that it has received a substantial investment from DW Healthcare Partners ("DWHP"), an exclusively healthcare-focused private equity firm, to promote the continued success of the company.

Founded in 1994, PDD provides data management, SAS programming, and statistical services for pharmaceutical and biotech clinical trials. PDD has a broad range of therapeutic expertise with a concentration in oncology. PDD's customers are small to medium-sized pharmaceutical and biotech companies that rely on PDD for high-quality control and analysis of the critical data collected throughout a trial process. The Company's services are supported by pddEtrials, a proprietary web-based clinical data management system utilized by both employees and clients.

PDD has developed a strong reputation within the marketplace for quality assurance, compliance, rapid turnaround times, and superior client service. Many of PDD's customers use the Company exclusively for their data management needs, which can span several different studies for each biotech/pharmaceutical company. PDD is led by Kelli Greene and Pete Sandgren who each have over 15 years of data management experience and are considered thought-leaders in the industry.

"This is a very exciting time for PDD," said Kelli Greene, President and CEO. "DWHP is the ideal partner as we look to increase our market share and expand our service offering."

"Elite CRO services are a core need of the growing CRO market, particularly in the market sector PDD serves," said Dr. Jay Benear of DWHP and new Chairman of the Board. "DWHP possesses the strengths necessary to augment PDD's potential, and we are eager to move forward."

Dr. Benear will be joined on the board by DWHP Managing Directors Doug Schillinger and Rod Boone.

About Pacific Data Designs, Inc.

Pacific Data Designs is a specialized Contract Research Organization ("CRO") providing data management and statistical services to the biotech, medical device, and pharmaceutical industries. PDD provides data management, SAS programming, and statistical services for pharmaceutical and biotech clinical trials and has a broad range of therapeutic expertise with a concentration in oncology. PDD's customers rely on PDD for high-quality control and analysis of the critical data collected throughout a trial process. For more information, please visit http://www.pdd.net.

About DW Healthcare Partners

DWHP is a leading private equity firm focused exclusively on the healthcare industry. With more than $200 million under management, DWHP is led by five seasoned healthcare executives with more than 100 years of combined industry experience. DWHP provides the capital, strategic guidance and acquisition expertise to accelerate the growth of leading healthcare businesses with proven management teams. DWHP has invested in numerous healthcare companies. Current portfolio investments include Pentec Health, Hill Top Research, Tandem Labs, and Verathon. For more information, please visit http://www.dwhp.com.


'/>"/>
SOURCE DW Healthcare Partners
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics
2. U.S. Invests $9.3 Billion in Research to Improve Health Globally
3. Blue Cross of California Invests $10.6 Million in Community Clinics Through the Investment in a Healthy California Program
4. Health IT Event Draws Experts to the Pacific Northwest
5. American Pacific Management to Present at CIBC World Markets 2nd Industrials Conference
6. Mylan Announces Appointment of John Montgomery as President, Asia Pacific
7. MediKeeper Closes Series A Financing Round with PacifiCap as Lead Investor
8. Pacific Valley Bank Approves $16.7 Million Loan to Mee Memorial Hospital for Healthcare Services in South Monterey County
9. Charles S. Cohen, Pacific Design Center Augment Their Support for AIDS Walk Los Angeles
10. Mayo Clinic Calls for Thorough Review of Canadian Pacifics Acquisition of the Dakota, Minnesota & Eastern Railroad
11. MSU engineering team designs innovative medical device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... 2016 , ... For many years, Andrew G. Zubinas has accumulated ... beauty of the Lithuanian language and its poetry inspired him in writing ... lyrically explores all aspects of a living, breathing forest where nothing ever stays the ...
(Date:12/5/2016)... ... December 05, 2016 , ... T.E.N., ... that nominations will be accepted from December 5, 2016 through March 3, ... include the Information Security Executive® of the Year, which recognizes executives who ...
(Date:12/5/2016)... ... December 05, 2016 , ... Worldwise ®, a ... design firm kathy ireland® Worldwide for five additional years, announced by Kevin Fick, ... exclusive licensing agreement three years ago to design and develop the kathy ireland® ...
(Date:12/5/2016)... York, NY (PRWEB) , ... December 05, 2016 ... ... companies to use a patent-pending blend of L-Citrulline and glutathione to enhance production ... Blend, a combination that studies have shown to produce NO twice as effectively ...
(Date:12/5/2016)... Nashville, Tennessee (PRWEB) , ... ... ... leader in strategic interoperability, today announced that the company will provide alerting ... platform. CIHIE has been recently awarded $1.7 million in federal funds as ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... R.I. , Dec. 5, 2016  CVS Health, ... it has received a perfect score of 100 percent ... consecutive year. The CEI is an annual national benchmarking ... to LGBT equality, administered by the Human Rights Campaign ... the rich diversity that our colleagues, customers and suppliers ...
(Date:12/5/2016)... PARSIPPANY, N.J. , Dec. 5, 2016 ... today announced preliminary safety and efficacy data from ... oral selective MDM2 inhibitor, suggesting that DS-3032 may ... relapsed/refractory acute myeloid leukemia (AML) and high-risk myelodysplastic ... part of the phase 1 study of DS-3032 were ...
(Date:12/5/2016)... -- John Seng, founder of Spectrum Science Communications , announced today ... Officer following two consecutive years of high double digit growth in ... 2014 and assumed management of the firm that Seng founded in ... Healthcare Agency of the Year and was selected among the Best ... ...
Breaking Medicine Technology: